Vasomedical Inc. Positioned to Seek Increased Reimbursement Coverage for EECP(R) Therapy

WESTBURY, N.Y.--(BUSINESS WIRE)--Vasomedical, Inc. (“Vasomedical”) (VASO.PK), a global provider of medical devices, today announced the execution of a definitive agreement with Edgary Consultants LLC to facilitate its effort to broaden reimbursement coverage of EECP® therapy, a proprietary technology for the treatment of certain cardiovascular diseases, with commercial third-party payers as well as Centers for Medicare and Medicaid Services (CMS).
MORE ON THIS TOPIC